XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cost of products sold $ (86)  
Gross profit 1,449  
Operating expenses:    
Research and development 3,531 $ 4,981
Selling and marketing 2,785  
General and administrative 17,722 12,242
Total operating expenses 24,038 17,223
Loss from operations (22,589) (17,223)
Other (expense)/income    
Unrealized foreign exchange loss (9) (10)
Amortization expense (149) (16)
Unrealized (loss)/gain on securities (184) (25)
Interest income 195 54
Interest expense (978) (126)
Total other (expense)/income (1,125) (123)
Net loss $ (23,714) $ (17,346)
Basic net loss per common share $ (0.90) $ (0.67)
Diluted net loss per common share $ (0.90) $ (0.67)
Weighted-average number of common shares outstanding basic 26,275 26,006
Weighted-average number of common shares outstanding diluted 26,275 26,006
PEDMARK    
Revenue $ 1,535